Identification of telomere dysfunction in Friedreich ataxia

Identification of telomere dysfunction in Friedreich ataxia

Bibliographic Details
Main Authors:	Anjomani Virmouni, Sara, Al-Mahdawi, Sahar, Sandi, Chiranjeevi, Yasaei, Hemad, Giunti, Paola, Slijepcevic, Predrag, Pook, Mark A.
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462004/

Similar Items

Epigenetic-based therapies for Friedreich ataxia
by: Sandi, Chiranjeevi, et al.
Published: (2014)

MutLα Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia
by: Ezzatizadeh, Vahid, et al.
Published: (2014)

Cellular, Molecular and Functional Characterisation of YAC Transgenic Mouse Models of Friedreich Ataxia
by: Anjomani Virmouni, Sara, et al.
Published: (2014)

A novel GAA-repeat-expansion-based mouse model of Friedreich’s ataxia
by: Anjomani Virmouni, Sara, et al.
Published: (2015)

Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy
by: Sandi, Chiranjeevi, et al.
Published: (2013)

Generation and Characterisation of Friedreich Ataxia YG8R Mouse Fibroblast and Neural Stem Cell Models
by: Sandi, Chiranjeevi, et al.
Published: (2014)

The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines
by: Motevalli, Azadeh, et al.
Published: (2014)

Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
by: Kargaran, Parisa K., et al.
Published: (2016)

Friedreich Ataxia Patient Tissues Exhibit Increased 5-Hydroxymethylcytosine Modification and Decreased CTCF Binding at the FXN Locus
by: Al-Mahdawi, Sahar, et al.
Published: (2013)

Analysis of telomere length and function in radiosensitive mouse and human cells in response to DNA-PKcs inhibition
by: Yasaei, Hemad, et al.
Published: (2013)

The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases
by: Al-Mahdawi, Sahar, et al.
Published: (2014)

Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
by: Tomassini, Barbara, et al.
Published: (2012)

Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
by: Sandi, Chiranjeevi, et al.
Published: (2011)

Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cells
by: Sapir, Ester, et al.
Published: (2011)

Hepatic mitochondrial dysfunction in Friedreich Ataxia
by: Stüwe, Sven H, et al.
Published: (2011)

Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia
by: Xia, Haiyan, et al.
Published: (2012)

'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'
by: Abeti, R, et al.
Published: (2016)

Pharmacological Screening Using an FXN-EGFP Cellular Genomic Reporter Assay for the Therapy of Friedreich Ataxia
by: Li, Lingli, et al.
Published: (2013)

Is Friedreich ataxia an epigenetic disorder?
by: Kumari, Daman, et al.
Published: (2012)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
by: Koeppen, Arnulf H., et al.
Published: (2015)

Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts
by: Khonsari, H, et al.
Published: (2016)

Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany
by: Giunti, Paola, et al.
Published: (2013)

Anaesthesia for a patient with Friedreich's ataxia
by: Ganesan, Ilango
Published: (2011)

Functional and Structural Brain Damage in Friedreich's Ataxia
by: Marinela Vavla, et al.
Published: (2018-09-01)

FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia
by: Chutake, Yogesh K., et al.
Published: (2015)

Friedreich's ataxia: the vicious circle hypothesis revisited
by: Bayot, Aurélien, et al.
Published: (2011)

Friedreich ataxia: metal dysmetabolism in dorsal root ganglia
by: Koeppen, Arnulf H, et al.
Published: (2013)

Friedreich Ataxia: current status and future prospects
by: Katrin Bürk
Published: (2017-04-01)

Frataxin levels in peripheral tissue in Friedreich ataxia
by: Lazaropoulos, Michael, et al.
Published: (2015)

IGF-1 in Friedreich’s Ataxia – proof-of-concept trial
by: Sanz-Gallego, Irene, et al.
Published: (2014)

Friedreich ataxia in Norway – an epidemiological, molecular and clinical study
by: Wedding, Iselin Marie, et al.
Published: (2015)

Friedreich's ataxia – a case of aberrant transcription termination?
by: Butler, Jill Sergesketter, et al.
Published: (2015)

Consensus clinical management guidelines for Friedreich ataxia
by: Corben, Louise A, et al.
Published: (2014)

Very Late-Onset Friedreich Ataxia with Laryngeal Dystonia
by: Rota, Silvia, et al.
Published: (2014)

Pms2 Suppresses Large Expansions of the (GAA·TTC)n Sequence in Neuronal Tissues
by: Bourn, Rebecka L., et al.
Published: (2012)

Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia
by: Hayashi, Genki, et al.
Published: (2014)

Massive Uterine Leiomyoma in a Patient with Friedreich's Ataxia: Is There a Possible Association?
by: Misiakos, Evangelos P., et al.
Published: (2011)

Understanding the genetic and molecular pathogenesis of Friedreich’s ataxia through animal and cellular models
by: Martelli, Alain, et al.
Published: (2012)

Effects of Friedreich's ataxia GAA repeats on DNA replication in mammalian cells
by: Chandok, Gurangad S., et al.
Published: (2012)

Long intronic GAA repeats causing Friedreich ataxia impede transcription elongation
by: Punga, Tanel, et al.
Published: (2010)